Quantcast

Rexahn Pharmaceuticals to move to Nasdaq

A Maryland biopharmaceutical company working on therapies for difficult-to-treat kinds of cancer is moving from from one stock exchange to another.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.